Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Cholecystokinin system is involved in the anorexigenic effect of peripherally applied palmitoylated prolactin-releasing peptide in fasted mice

Z. Pirník, L. Kořínková, J. Osacká, B. Železná, J. Kuneš, L. Maletínská

. 2021 ; 70 (4) : 579-590. [pub] 20210601

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22007900

Prolactin-releasing peptide (PrRP) has been proposed to mediate the central satiating effects of cholecystokinin (CCK) through the vagal CCK1 receptor. PrRP acts as an endogenous ligand of G protein-coupled receptor 10 (GPR10), which is expressed at the highest levels in brain areas related to food intake regulation, e.g., the paraventricular hypothalamic nucleus (PVN) and nucleus of the solitary tract (NTS). The NTS and PVN are also significantly activated after peripheral CCK administration. The aim of this study was to determine whether the endogenous PrRP neuronal system in the brain is involved in the central anorexigenic effect of the peripherally administered CCK agonist JMV236 or the CCK1 antagonist devazepide and whether the CCK system is involved in the central anorexigenic effect of the peripherally applied lipidized PrRP analog palm-PrRP31 in fasted lean mice. The effect of devazepide and JMV236 on the anorexigenic effects of palm-PrRP31 as well as devazepide combined with JMV236 and palm-PrRP31 on food intake and Fos cell activation in the PVN and caudal NTS was examined. Our results suggest that the anorexigenic effect of JMV236 is accompanied by activation of PrRP neurons of the NTS in a CCK1 receptor-dependent manner. Moreover, while the anorexigenic effect of palm-PrRP31 was not affected by JMV236, it was partially attenuated by devazepide in fasted mice. The present findings indicate that the exogenously influenced CCK system may be involved in the central anorexigenic effect of peripherally applied palm-PrRP31, which possibly indicates some interaction between the CCK and PrRP neuronal systems.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc22007900
003      
CZ-PrNML
005      
20220324135547.0
007      
ta
008      
220309s2021 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934694 $2 doi
035    __
$a (PubMed)34062082
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Pirník, Zdenko $7 xx0170306 $u Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic $u Biomedical Research Center, Slovak Academy of Sciences, Institute of Experimental Endocrinology, Bratislava, Slovak Republic
245    10
$a Cholecystokinin system is involved in the anorexigenic effect of peripherally applied palmitoylated prolactin-releasing peptide in fasted mice / $c Z. Pirník, L. Kořínková, J. Osacká, B. Železná, J. Kuneš, L. Maletínská
504    __
$a Literatura
520    9_
$a Prolactin-releasing peptide (PrRP) has been proposed to mediate the central satiating effects of cholecystokinin (CCK) through the vagal CCK1 receptor. PrRP acts as an endogenous ligand of G protein-coupled receptor 10 (GPR10), which is expressed at the highest levels in brain areas related to food intake regulation, e.g., the paraventricular hypothalamic nucleus (PVN) and nucleus of the solitary tract (NTS). The NTS and PVN are also significantly activated after peripheral CCK administration. The aim of this study was to determine whether the endogenous PrRP neuronal system in the brain is involved in the central anorexigenic effect of the peripherally administered CCK agonist JMV236 or the CCK1 antagonist devazepide and whether the CCK system is involved in the central anorexigenic effect of the peripherally applied lipidized PrRP analog palm-PrRP31 in fasted lean mice. The effect of devazepide and JMV236 on the anorexigenic effects of palm-PrRP31 as well as devazepide combined with JMV236 and palm-PrRP31 on food intake and Fos cell activation in the PVN and caudal NTS was examined. Our results suggest that the anorexigenic effect of JMV236 is accompanied by activation of PrRP neurons of the NTS in a CCK1 receptor-dependent manner. Moreover, while the anorexigenic effect of palm-PrRP31 was not affected by JMV236, it was partially attenuated by devazepide in fasted mice. The present findings indicate that the exogenously influenced CCK system may be involved in the central anorexigenic effect of peripherally applied palm-PrRP31, which possibly indicates some interaction between the CCK and PrRP neuronal systems.
650    _2
$a zvířata $7 D000818
650    _2
$a anorektika $x aplikace a dávkování $7 D001067
650    _2
$a chemokiny CC $x účinky léků $x metabolismus $7 D019742
650    _2
$a cholecystokinin $x metabolismus $7 D002766
650    _2
$a devazepid $x aplikace a dávkování $7 D020109
650    _2
$a přijímání potravy $x účinky léků $7 D004435
650    _2
$a omezení příjmu potravy $7 D005215
650    _2
$a stravovací zvyklosti $x účinky léků $7 D005247
650    _2
$a antagonisté hormonů $x aplikace a dávkování $7 D006727
650    _2
$a injekce intraperitoneální $7 D007274
650    _2
$a injekce subkutánní $7 D007279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a nucleus paraventricularis hypothalami $x účinky léků $x metabolismus $7 D010286
650    _2
$a peptidové fragmenty $x aplikace a dávkování $7 D010446
650    _2
$a hormon uvolňující prolaktin $x aplikace a dávkování $x analogy a deriváty $7 D056690
650    _2
$a protoonkogenní proteiny c-fos $x metabolismus $7 D016760
650    _2
$a signální transdukce $7 D015398
650    _2
$a sinkalid $x aplikace a dávkování $x analogy a deriváty $7 D012844
650    _2
$a nucleus solitarius $x účinky léků $x metabolismus $7 D017552
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kořínková, Lucia $7 xx0243700 $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic $u First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Bundzíková, Jana $7 xx0196296 $u Biomedical Research Center, Slovak Academy of Sciences, Institute of Experimental Endocrinology, Bratislava, Slovak Republic
700    1_
$a Železná, Blanka $7 xx0206931 $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Kuneš, Jaroslav, $d 1948- $7 nlk19990073450 $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Maletínská, Lenka, $d 1965- $7 xx0080235 $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 70, č. 4 (2021), s. 579-590
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34062082 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20220309 $b ABA008
991    __
$a 20220324135541 $b ABA008
999    __
$a ok $b bmc $g 1773030 $s 1159093
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 70 $c 4 $d 579-590 $e 20210601 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20220309

Find record

Citation metrics

Archiving options